Showing 12,241 - 12,260 results of 30,599 for search '(( a ((((linear decrease) OR (teer decrease))) OR (larger decrease)) ) OR ( a large decrease ))', query time: 0.79s Refine Results
  1. 12241

    Location of facilities in Kano and Lagos. by Charity Oga-Omenka (6635432)

    Published 2023
    “…<div><p>Nigeria has the second largest share of undiagnosed TB cases in the world and a large private health sector estimated to be the point of initial care-seeking for 67% of TB patients. …”
  2. 12242

    Primers and shRNAs. by Huanzhou Xu (8129922)

    Published 2025
    “…<div><p>Epstein-Barr virus (EBV), a common gamma-herpesvirus linked to various malignancies, exploits host cellular mechanisms to promote oncogenesis. …”
  3. 12243

    Planning data for different plots. by Manxian Yang (20521600)

    Published 2025
    “…For single-field operations, a path planning approach is developed that minimizes energy consumption. …”
  4. 12244

    Common turning methods. by Manxian Yang (20521600)

    Published 2025
    “…For single-field operations, a path planning approach is developed that minimizes energy consumption. …”
  5. 12245

    Algorithm comparison. by Manxian Yang (20521600)

    Published 2025
    “…For single-field operations, a path planning approach is developed that minimizes energy consumption. …”
  6. 12246

    A single systemic prophylactic treatment with CpG-C results in long-term reduction of metastatic burden in the brain. by Amit Benbenishty (6524375)

    Published 2019
    “…Interestingly, in two CpG-C–treated animals, the bioluminescent signal gradually decreased and disappeared on day 21. (<b>d</b>) Ex vivo bioluminescence imaging of the brains from the syngeneic model indicated a 48-fold reduced tumor burden (total flux) in CpG-C–treated animals (<i>n</i> = 6; two-tailed unpaired Student <i>t</i> test, <i>t</i><sub>(10)</sub> = 3.722, <i>p</i> = 0.0040). …”
  7. 12247

    Service disruptions due to COVID-19. by Charity Oga-Omenka (6635432)

    Published 2023
    “…<div><p>Nigeria has the second largest share of undiagnosed TB cases in the world and a large private health sector estimated to be the point of initial care-seeking for 67% of TB patients. …”
  8. 12248

    Facility closures due to COVID-19, 2020–2021. by Charity Oga-Omenka (6635432)

    Published 2023
    “…<div><p>Nigeria has the second largest share of undiagnosed TB cases in the world and a large private health sector estimated to be the point of initial care-seeking for 67% of TB patients. …”
  9. 12249

    PLWNT operation diagram. by Yuanjia Gu (12626567)

    Published 2023
    “…CFS patients are often accompanied by functional gastrointestinal diseases (FGIDs), which lead to decreased quality of life and increased fatigue. Prolong-life-with-nine-turn-method (PLWNT) is a kind of physical and mental exercise. …”
  10. 12250

    Study flow chart. by Yuanjia Gu (12626567)

    Published 2023
    “…CFS patients are often accompanied by functional gastrointestinal diseases (FGIDs), which lead to decreased quality of life and increased fatigue. Prolong-life-with-nine-turn-method (PLWNT) is a kind of physical and mental exercise. …”
  11. 12251

    Intervention schedules. by Yuanjia Gu (12626567)

    Published 2023
    “…CFS patients are often accompanied by functional gastrointestinal diseases (FGIDs), which lead to decreased quality of life and increased fatigue. Prolong-life-with-nine-turn-method (PLWNT) is a kind of physical and mental exercise. …”
  12. 12252

    Table 1_Association between relative fat mass and risk of arthritis: a study based on populations in China and the United States.docx by Yang Yang (45629)

    Published 2025
    “…In the American female population, a non-linear correlation was observed between RFM and arthritis, with elevated RFM below the threshold of 35.85 exhibiting a modest decrease in the risk of arthritis, and elevated RFM above the threshold demonstrating a substantial increase in the risk of arthritis. …”
  13. 12253

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”
  14. 12254

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”
  15. 12255

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”
  16. 12256

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”
  17. 12257

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”
  18. 12258

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”
  19. 12259

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”
  20. 12260

    Combining Ultrasound and Capillary-Embedded T‑Junction Microfluidic Devices to Scale Up the Production of Narrow-Sized Microbubbles through Acoustic Fragmentation by Aaqib H. Khan (9407159)

    Published 2022
    “…The rate of microbubble production was found to increase from 180 microbubbles/s in the absence of ultrasound to (6.5 ± 1.2) × 10<sup>6</sup> bubble/s in the presence of ultrasound (100% ultrasound amplitude). When stored in a closed environment, the microbubbles were observed to be stable for up to 30 days, with the concentration of the microbubble suspension decreasing from ∼2.81 × 10<sup>9</sup>/mL to ∼2.3 × 10<sup>6</sup>/mL and the size changing from 1.73 ± 0.2 to 1.45 ± 0.3 μm at the end of 30 days. …”